Chengdu Easton Biopharmaceuticals Co Ltd
SSE:688513
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
G
|
Gofore Oyj
OMXH:GOFORE
|
FI |
|
Premier Ltd
NSE:PREMIER
|
IN |
|
D
|
DIT Group Ltd
HKEX:726
|
HK |
|
Hudson Investment Group Ltd
ASX:HGL
|
AU |
|
A
|
Arion Entertainment Singapore Ltd
SGX:YYB
|
SG |
Chengdu Easton Biopharmaceuticals Co Ltd
Research & Development
Chengdu Easton Biopharmaceuticals Co Ltd
Research & Development Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Research & Development | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
|
Chengdu Easton Biopharmaceuticals Co Ltd
SSE:688513
|
Research & Development
-¥241.8m
|
CAGR 3-Years
-7%
|
CAGR 5-Years
-10%
|
CAGR 10-Years
N/A
|
|
|
H
|
Hansoh Pharmaceutical Group Company Ltd
HKEX:3692
|
Research & Development
-¥2.9B
|
CAGR 3-Years
-17%
|
CAGR 5-Years
-23%
|
CAGR 10-Years
N/A
|
|
|
Jiangsu Hengrui Pharmaceuticals Co Ltd
SSE:600276
|
Research & Development
-¥7B
|
CAGR 3-Years
-10%
|
CAGR 5-Years
-10%
|
CAGR 10-Years
N/A
|
|
|
Yunnan Baiyao Group Co Ltd
SZSE:000538
|
Research & Development
-¥356.2m
|
CAGR 3-Years
-1%
|
CAGR 5-Years
-13%
|
CAGR 10-Years
N/A
|
|
|
Zhejiang Nhu Co Ltd
SZSE:002001
|
Research & Development
-¥1.1B
|
CAGR 3-Years
-8%
|
CAGR 5-Years
-17%
|
CAGR 10-Years
N/A
|
|
|
S
|
Sichuan Biokin Pharmaceutical Co Ltd
SSE:688506
|
Research & Development
-¥1.4B
|
CAGR 3-Years
-77%
|
CAGR 5-Years
-54%
|
CAGR 10-Years
N/A
|
|
Chengdu Easton Biopharmaceuticals Co Ltd
Glance View
Chengdu Easton Bio Pharmaceuticals Co., Ltd. engages in the research and development, production, and sale of chemical raw materials and chemical drug preparations. The company is headquartered in Chengdu, Sichuan and currently employs 1,188 full-time employees. The company went IPO on 2020-09-02. The firm's main products are chemical generic drugs. Its products include nalmefene hydrochloride injection, caffeine citrate injection, ibuprofen injection, bisoprolol fumarate tablets, ubenimex, etc. Its products are used in the fields of anesthesia and analgesia, cardiovascular, anti-tumor, digestion and children's medicine. The firm operates its businesses within the China market and to overseas markets such as Russia, Switzerland, Tunisia, Germany, South Korea and Japan.
See Also
What is Chengdu Easton Biopharmaceuticals Co Ltd's Research & Development?
Research & Development
-241.8m
CNY
Based on the financial report for Dec 31, 2024, Chengdu Easton Biopharmaceuticals Co Ltd's Research & Development amounts to -241.8m CNY.
What is Chengdu Easton Biopharmaceuticals Co Ltd's Research & Development growth rate?
Research & Development CAGR 5Y
-10%
Over the last year, the Research & Development growth was -10%. The average annual Research & Development growth rates for Chengdu Easton Biopharmaceuticals Co Ltd have been -7% over the past three years , -10% over the past five years .
